Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Barrett Esophagus × Omeprazole × Clear all

Phase

Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Inflammation 2 Hyperuricemia 1 Gout 1 Cardiovascular Diseases 1 Barrett Esophagus 1 Arthritis 1

Interventions

Esomeprazole 3 rofecoxib 1 Prednisolone 1 Omeprazole 1 Lansoprazole 1 Gastropexy 1 Fundoplication 1 Docosahexaenoic Acids 1 Dexlansoprazole 1 Cryotherapy 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01093755 2016-03-17

Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?

Mayo Clinic

Phase 4 Completed

30 enrolled 12 charts

Gastrointestinal

Barrett Esophagus, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡